Related Experiment Video
Updated: May 23, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
A resource description framework (RDF) model of named entity co-occurrences in biomedical literature and its
Qingliang Li1, Sunghwan Kim1, Leonid Zaslavsky1
1National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, 20894, USA.
Abstract:
Named entities, such as chemicals/drugs, genes/proteins, and diseases, and their associations are not only important components of biomedical literature, but also the foundation of creating biomedical knowledgebases and knowledge graphs. This work addresses the challenges of expressing co-occurrence associations between named entities extracted from a biomedical literature corpus in a machine-readable format. We developed a Resource Description Framework (RDF) data model and integrated it into the PubChemRDF resource, which is freely accessible and publicly available. The developed co-occurrence data model was populated into a triplestore with named entities and their associations derived from text mining of millions of biomedical references found in PubMed. The utility of the data model was demonstrated through multiple use cases. Together with meta-data modeling of the references including the information about the author, journal, grant, and funding agency, this data model allows researchers to address pertinent biomedical questions through SPARQL queries and helps to exploit biomedical knowledge in various user perspectives and use cases.
More Related Videos
Related Concept Videos
Drug Nomenclature
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Discovery: Overview
Quantitative Aspects of Drug-Receptor Interaction
Covalently Linked Protein Regulators
Bioavailability: Overview

